Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Does PAD and microcirculation status impact the tissue availability of intravenously administered antibiotics in patients with infected diabetic foot? Results of the DFIATIM substudy

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985904%3A_____%2F24%3A00586271" target="_blank" >RIV/67985904:_____/24:00586271 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11120/24:43927061 RIV/00216208:11130/24:10480488 RIV/00023001:_____/24:00084814

  • Výsledek na webu

    <a href="https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1326179/full" target="_blank" >https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1326179/full</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3389/fendo.2024.1326179" target="_blank" >10.3389/fendo.2024.1326179</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Does PAD and microcirculation status impact the tissue availability of intravenously administered antibiotics in patients with infected diabetic foot? Results of the DFIATIM substudy

  • Popis výsledku v původním jazyce

    Aims/hypothesis: The aim of this substudy (Eudra CT No:2019-001997-27) was to assess ATB availability in patients with infected diabetic foot ulcers (IDFUs) in the context of microcirculation and macrocirculation status. Methods: For this substudy, we enrolled 23 patients with IDFU. Patients were treated with boluses of amoxicillin/clavulanic acid(AMC)(12patients) or ceftazidime(CTZ)(11patients). After induction of a steady ATB state, microdialysis was performed near the IDFU. Tissue fluid samples from the foot and blood samples from peripheral blood were taken within 6 hours. ATB potential efficacy was assessed by evaluating the maximum serum and tissue ATB concentrations(C-max and Cmax-tissue)and the percentage of time the unbound drug tissue concentration exceeds the minimum inhibitory concentration (MIC)(>= 100% (tissue) and >= 50%/60% (tissue) fT>MIC). Vascular status was assessed by triplex ultrasound, ankle-brachial and toe-brachial index tests, occlusive plethysmography comprising two arterial flow phases, and transcutaneous oxygen pressure(TcPO2). Results: Following bolus administration, the C-max of AMC was 91.8 +/- 52.5 mu gmL(-1) and the Cmax-tissue of AMC was 7.25 +/- 4.5 mu gmL(-1)(P<0.001). The C-max for CTZ was 186.8 +/- 44.1 mu gmL(-1) and the Cmax-tissue of CTZ was 18.6 +/- 7.4 mu gmL(-1)(P<0.0001). Additionally, 67% of patients treated with AMC and 55% of those treated with CTZ achieved tissue fT>MIC levels exceeding 50% and 60%, respectively. We observed positive correlations between both Cmax-tissue and AUC(tissue) and arterial flow. Specifically, the correlation coefficient for the first phase was r=0.42 (P=0.045), and for the second phase, it was r=0.55(P=0.01)and r=0.5(P=0.021). Conclusions: Bactericidal activity proved satisfactory in only half to two-thirds of patients with IDFUs, an outcome that appears to correlate primarily with arterial flow.

  • Název v anglickém jazyce

    Does PAD and microcirculation status impact the tissue availability of intravenously administered antibiotics in patients with infected diabetic foot? Results of the DFIATIM substudy

  • Popis výsledku anglicky

    Aims/hypothesis: The aim of this substudy (Eudra CT No:2019-001997-27) was to assess ATB availability in patients with infected diabetic foot ulcers (IDFUs) in the context of microcirculation and macrocirculation status. Methods: For this substudy, we enrolled 23 patients with IDFU. Patients were treated with boluses of amoxicillin/clavulanic acid(AMC)(12patients) or ceftazidime(CTZ)(11patients). After induction of a steady ATB state, microdialysis was performed near the IDFU. Tissue fluid samples from the foot and blood samples from peripheral blood were taken within 6 hours. ATB potential efficacy was assessed by evaluating the maximum serum and tissue ATB concentrations(C-max and Cmax-tissue)and the percentage of time the unbound drug tissue concentration exceeds the minimum inhibitory concentration (MIC)(>= 100% (tissue) and >= 50%/60% (tissue) fT>MIC). Vascular status was assessed by triplex ultrasound, ankle-brachial and toe-brachial index tests, occlusive plethysmography comprising two arterial flow phases, and transcutaneous oxygen pressure(TcPO2). Results: Following bolus administration, the C-max of AMC was 91.8 +/- 52.5 mu gmL(-1) and the Cmax-tissue of AMC was 7.25 +/- 4.5 mu gmL(-1)(P<0.001). The C-max for CTZ was 186.8 +/- 44.1 mu gmL(-1) and the Cmax-tissue of CTZ was 18.6 +/- 7.4 mu gmL(-1)(P<0.0001). Additionally, 67% of patients treated with AMC and 55% of those treated with CTZ achieved tissue fT>MIC levels exceeding 50% and 60%, respectively. We observed positive correlations between both Cmax-tissue and AUC(tissue) and arterial flow. Specifically, the correlation coefficient for the first phase was r=0.42 (P=0.045), and for the second phase, it was r=0.55(P=0.01)and r=0.5(P=0.021). Conclusions: Bactericidal activity proved satisfactory in only half to two-thirds of patients with IDFUs, an outcome that appears to correlate primarily with arterial flow.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    10606 - Microbiology

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/NU20-01-00078" target="_blank" >NU20-01-00078: Racionalizace antibiotické terapie infekce u syndromu diabetické nohy a její vztah ke gastrointestinálnímu traktu</a><br>

  • Návaznosti

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Ostatní

  • Rok uplatnění

    2024

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Frontiers in Endocrinology

  • ISSN

    1664-2392

  • e-ISSN

    1664-2392

  • Svazek periodika

    15

  • Číslo periodika v rámci svazku

    May 7

  • Stát vydavatele periodika

    CH - Švýcarská konfederace

  • Počet stran výsledku

    11

  • Strana od-do

    1326179

  • Kód UT WoS článku

    001227729200001

  • EID výsledku v databázi Scopus

    2-s2.0-85193637276